Bion Environmental Technologies, Inc.

AI-generated fair value estimate for this company.

Method: Probability-weighted 10-year DCF: conditional-on-commercialization free cash flow ramping from -$1.0M (yr1) to $10.0M (yr10) as Gen3Tech bolt-on ammonia-recovery/organic-fertilizer units are deployed under signed offtake commitments; 20% discount rate; 3% terminal growth; 25% estimated probability of reaching that commercial scale given the going-concern doubt and $43,553 cash balance at 3/31/2026; resulting expected value divided by an estimated ~130 million fully-diluted future share count reflecting the dilutive capital raises management says are required ($3-10M+ needed before any commercial deployment, each project needing 8M+).

Reasoning: Bion is a pre-revenue, negative-equity (-$6.59M) development-stage company with explicit going-concern language in its 10-Q and zero TTM revenue, so a standard unlevered FCF DCF on current financials would be meaningless; a heavily risk- and dilution-adjusted, probability-weighted DCF on a hypothetical commercialization path is the most defensible way to attach a real calculated value instead of fabricating one.